Cancer type-dependent correlations between TP53 mutations and antitumor immunity

Kastenhuber, 2017, Putting p53 in context, Cell, 170, 1062, 10.1016/j.cell.2017.08.028

Wang, 2017, TP53 mutations, expression and interaction networks in human cancers, Oncotarget, 8, 624, 10.18632/oncotarget.13483

Zitvogel, 2015, CANCER. A p53-regulated immune checkpoint relevant to cancer, Science, 349, 476, 10.1126/science.aac8475

Textor, 2011, Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2, Cancer Res., 71, 5998, 10.1158/0008-5472.CAN-10-3211

Shatz, 2012, The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells, Cancer Res., 72, 3948, 10.1158/0008-5472.CAN-11-4134

Guo, 2017, Local activation of p53 in the tumor microenvironment overcomes immune suppression and enhances antitumor immunity, Cancer Res., 77, 2292, 10.1158/0008-5472.CAN-16-2832

Jiang, 2018, Immunogenomics analysis reveals that TP53 mutations inhibit tumor immunity in gastric cancer, Transl. Oncol., 11, 1171, 10.1016/j.tranon.2018.07.012

Wang, 2013, p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1, Nat. Commun., 4, 2359, 10.1038/ncomms3359

Dong, 2017, Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma, Clin. Cancer Res., 23, 3012, 10.1158/1078-0432.CCR-16-2554

Xiao, 2018, TP53 mutation as potential negative predictor for response of anti-CTLA-4 therapy in metastatic melanoma, EBioMedicine, 32, 119, 10.1016/j.ebiom.2018.05.019

Ham, 2019, TP53 gain-of-function mutation promotes inflammation in glioblastoma, Cell Death Differ., 26, 409, 10.1038/s41418-018-0126-3

Lyu, 2019, Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer, Comput. Struct. Biotechnol. J., 17, 1020, 10.1016/j.csbj.2019.07.009

Liu, 2019, TP53 mutations promote immunogenic activity in breast cancer, J. Oncol., 2019, 1

Samstein, 2019, Tumor mutational load predicts survival after immunotherapy across multiple cancer types, Nat. Genet., 51, 202, 10.1038/s41588-018-0312-8

Goodman, 2017, Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers, Mol. Cancer Ther., 16, 2598, 10.1158/1535-7163.MCT-17-0386

Davoli, 2017, Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy, Science, 355, 10.1126/science.aaf8399

Rizvi, 2015, Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer, Science, 348, 124, 10.1126/science.aaa1348

Hanzelmann, 2013, GSVA: gene set variation analysis for microarray and RNA-seq data, BMC Bioinformatics, 14, 7, 10.1186/1471-2105-14-7

Kanehisa, 2017, KEGG: new perspectives on genomes, pathways, diseases and drugs, Nucleic Acids Res., 45, D353, 10.1093/nar/gkw1092

Carter, 2012, Absolute quantification of somatic DNA alterations in human cancer, Nat. Biotechnol., 30, 413, 10.1038/nbt.2203

Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U. S. A., 102, 15545, 10.1073/pnas.0506580102

Li, 2016, Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging, Oncotarget, 7, 11838, 10.18632/oncotarget.7864

Eischen, 2016, Genome stability requires p53, Cold Spring Harb. Perspect. Med., 6, 10.1101/cshperspect.a026096

Patel, 2015, PD-L1 expression as a predictive biomarker in cancer immunotherapy, Mol. Cancer Ther., 14, 847, 10.1158/1535-7163.MCT-14-0983

Andrysik, 2017, Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity, Genome Res., 27, 1645, 10.1101/gr.220533.117

He, 2019, Identification of genomic features associated with immunotherapy response in gastrointestinal cancers, World J. Gastrointest. Oncol., 11, 270, 10.4251/wjgo.v11.i4.270

Mayakonda, 2018, Maftools: efficient and comprehensive analysis of somatic variants in cancer, Genome Res., 28, 1747, 10.1101/gr.239244.118

Haanen, 2017, Converting cold into hot tumors by combining immunotherapies, Cell, 170, 1055, 10.1016/j.cell.2017.08.031